Major shareholder announcement - BlackRock, Inc.

BlackRock, Inc. reported that its voting rights in ChemoMetec rose to 15.08% on 29 September 2026, exceeding the 15% disclosure threshold under Danish law; all of the reported position was attached to shares, with 0.00% through financial instruments. The notice also recounts prior 2026 position disclosures, including BlackRock, Inc.’s 13.03% total position on 28 August.

Analysis

The disclosure is more informative about voting concentration than about fundamental conviction. BlackRock’s reported position is held through an asset manager; it does not establish a proprietary bet, activist intent, or a durable increase in beneficial ownership. Changes may reflect client flows, mandate reallocations, or changes in the voting-share denominator as well as purchases. The earlier threshold crossings and reversals reinforce that ownership can move around reporting levels.

For ChemoMetec, a larger block could reduce effective free float and amplify price moves in a relatively less-liquid stock, while giving BlackRock more voting weight on governance matters. That becomes material only if followed by explicit engagement, a contested vote, or sustained accumulation. There is no direct earnings read-through to BlackRock from this notice.

Near term, the disclosure may support a sentiment bid but is not a standalone catalyst. Over 1–3 months, monitor subsequent ownership notices, trading liquidity, and any governance engagement. Over 6–18 months, persistent concentration could matter for control and voting outcomes, but the filing alone does not establish that path. Contrarian point: treating a threshold crossing as a high-conviction institutional endorsement overstates what the data can show.

Key Decisions for Investors

• No trade on the notice alone. Avoid interpreting BlackRock’s reported voting stake as proprietary capital or an activist position.
• For CHEMM, track subsequent threshold filings, trading volume/free float, and any public stewardship or voting activity; reassess if accumulation persists or governance engagement becomes explicit.
• For BLK, treat this as immaterial to earnings absent evidence of a material change in fee-generating assets or a related business development.
• Falsification/watch item: if later filings show the position reversing, or the company confirms no engagement and the stock’s liquidity remains unaffected, discount the ownership-concentration thesis.